Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00288002
What this trial is testing

Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 1,500
Not applicableStudy completedNCT01407692
What this trial is testing

Menstrual Cycle Hormones and Eating Behavior

Who this might be right for
Dietary HabitsFood Preference
USDA, Western Human Nutrition Research Center 24
Testing effectiveness (Phase 2)Study completedNCT02007512
What this trial is testing

Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Pfizer 247
Testing effectiveness (Phase 2)Study completedNCT02475265
What this trial is testing

Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa

Who this might be right for
Anorexia NervosaOsteoporosis
Massachusetts General Hospital 11
Not applicableStudy completedNCT06363812
What this trial is testing

Probability of OncotypeDx to Reallocate As Low or High Risk of Recurrence Breast Cancer Patients with Uncertain Biology

Who this might be right for
Breast Cancer
Fondazione Sandro Pitigliani 258
Not applicableEnded earlyNCT00358098
What this trial is testing

Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
AHS Cancer Control Alberta 51
Testing effectiveness (Phase 2)Study completedNCT00000612
What this trial is testing

Soy Estrogen Alternative Study (SEA)

Who this might be right for
Cardiovascular DiseasesEndometrial HyperplasiaHeart Diseases+3 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT02556411
What this trial is testing

Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)

Who this might be right for
AdenomyosisChronic Pelvic Pain
University of Cagliari 50
Not applicableLooking for participantsNCT06866119
What this trial is testing

Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency

Who this might be right for
Primary Ovarian InsufficiencyPremature MenopauseMetabolic Complications+2 more
Massachusetts General Hospital 45
Not applicableEnded earlyNCT00565916
What this trial is testing

Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism

Who this might be right for
Postmenopausal Syndrome
Washington University School of Medicine 22
Testing effectiveness (Phase 2)Study completedNCT00856492
What this trial is testing

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 215
Early research (Phase 1)Study completedNCT04647487
What this trial is testing

LY3484356 in Women With Breast Cancer Before Having Surgery

Who this might be right for
Breast Cancer
Eli Lilly and Company 87
Testing effectiveness (Phase 2)Study completedNCT02860000
What this trial is testing

Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer

Who this might be right for
Estrogen Receptor StatusHER2/Neu NegativeInvasive Breast Carcinoma+6 more
Mayo Clinic 96
Early research (Phase 1)Study completedNCT00396799
What this trial is testing

Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women

Who this might be right for
Menopause
Wyeth is now a wholly owned subsidiary of Pfizer
Very early researchLooking for participantsNCT05659797
What this trial is testing

FES BPET-DBT in Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 20
Large-scale testing (Phase 3)UnknownNCT00541086
What this trial is testing

Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery

Who this might be right for
Breast Cancer
Gruppo Italiano Mammella (GIM) 3,697
Not applicableEnded earlyNCT05802303
What this trial is testing

Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation

Who this might be right for
Frozen Embryo TransferInfertility, Female
Indira IVF Hospital Pvt Ltd 172
Testing effectiveness (Phase 2)Ended earlyNCT02395627
What this trial is testing

Reversing Therapy Resistance With Epigenetic-Immune Modification

Who this might be right for
Breast Neoplasms
University of California, San Francisco 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT05296746
What this trial is testing

Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer

Who this might be right for
Breast Cancer Stage II
SOLTI Breast Cancer Research Group 1,100
Large-scale testing (Phase 3)UnknownNCT03351062
What this trial is testing

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

Who this might be right for
Breast Cancer Female
Chinese Anti-Cancer Association 844
Next Page